In each issue of Pharmaceutical Engineering®, we introduce a member of the ISPE staff who provides ISPE members with key information and services. Meet Lynda Goldbach, Manager of Publications, Publications Department.
I work primarily on our Guidance Documents, assisting our volunteer teams through the development process, and manage the publication of all the guides. I also do the final production for both print and electronic versions. I used to work on PE magazine, in the marketing department producing our brochures, newsletters, and other promotional pieces, and managed our member database when we had a lot fewer members.
I love working with our members and learning about all the different areas of the pharmaceutical industry. One of my favorite things is taking the rough-looking guide drafts and turning them into a real “book.”
I like to spend time with my husband and daughters, either at home crafting or at Disney World (our “second home”). I also enjoy teaching tricks and agility moves to our two Australian shepherds.
On October 29, 1986, a nervous teenager started her first day at ISPE. She was hired to perform data entry on a temporary, part-time basis. At the time, there were six people on staff, including the new hire and Executive Director Bob Best, and less than 2,000 members. The small staff size meant it would be “all hands on deck” for every facet of operations. It also meant that this new part-timer had the opportunity to learn anything she wanted to about ISPE—and so she did. She worked on Pharmaceutical Engineering, produced countless materials for the marketing department, and managed the member database. Eventually, she found her home in Guidance Documents in 1998.
Thirty-five years, four CEOs, 46 ISPE employees, and 16,000 members later, this nervous teenager has evolved into one of the most important contributors to ISPE as an organization, and to the industry as a whole. A skilled graphic designer and production/layout professional, her mark is on all Guidance Documents produced by ISPE, with the exception of one (if you’re curious, the first Baseline Guide on Bulk Pharmaceutical Chemicals). She’s collaborated with hundreds of volunteers to develop our prestigious ISPE Guidance Documents, the gold standard in the industry. To date, she has worked on a total of 240 unique products in the Guidance Documents space, including bound, PDF, CD, and myriad translated editions!
Please join me in thanking Lynda for her dedication and contributions to the organization and industry and congratulating her on a very happy 35th ISPE Work Anniversary!
Rochelle May, Senior Director, PublicationsIn the pharmaceutical industry, which is highly regulated, aseptic processing is a critical component that ensures the sterility of products. Regulators have a set of comprehensive requirements that minimize the risk of contamination. Regulators set the requirements; however, the industry has an obligation to the patients who rely on and expect a drug that is safe and free of contamination....
Like any investment in digital manufacturing systems, demonstrating business payback before and after investment is critical to getting MES projects approved and verifying profitability after investment. Whether it is introducing MES, expanding it to additional sites, switching software, upgrading existing software, or developing electronic production records (EPR) for new drug products,...
Sustainability is emerging as a pivotal force influencing the pharmaceutical industry’s dynamics and steering companies towards transformative change. The focus of this analysis is to delve into the sustainability key performance indicators (KPIs) of prominent pharmaceutical players, namely Pfizer, Sanofi, Glaxo Smith Kline (GSK), Becton Dickinson, Johnson & Johnson, Abbott, Eli Lilly, and...